Skip to main content
Top

Angiogenesis

Issue 1/2001

Content (13 Articles)

Editorial Commentary

From the Editor's desk

An ex vivo angiogenesis assay utilizing commercial porcine carotidartery: Modification of the rat aortic ring assay

Janet Stiffey-Wilusz, Judith A. Boice, John Ronan, Anthony M. Fletcher, Matt S. Anderson

Mg++-induced endothelial cell migration: Substratum selectivity and receptor-involvement

Karen A. Lapidos, Elisa C. Woodhouse, Elise C. Kohn, Laura Masiero

Production and characterization of a Tie2 agonist monoclonal antibody

Michael J. Hansbury, Roberto F. Nicosia, Wen-Hui Zhu, Steven J. Holmes, James D. Winkler

Platelets and vascular endothelial growth factor (VEGF): A morphological and functional study

Roberto Salgado, Ina Benoy, Johannes Bogers, Reinhilde Weytjens, Peter Vermeulen, Luc Dirix, Eric Van Marck

Designed β-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells

Kevin H. Mayo, Daisy W. J. van der Schaft, Arjan W. Griffioen

Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro

Pieter Koolwijk, Erna Peters, Bea van der Vecht, Carsten Hornig, Herbert A. Weich, Kari Alitalo, Daniel J. Hicklin, Yan Wu, Larry Witte, Victor W.M. van Hinsbergh

CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism

Lillian B. Nanney, Barbara D. Wamil, Jeffrey Whitsitt, Nancy L. Cardwell, Jeffrey M. Davidson, He-Ping Yan, Carl G. Hellerqvist

Feto-maternal interface of human placenta inhibits angiogenesis in the chick chorioallantoic membrane (CAM) assay

Thomas Stallmach, Christophe Duc, Esther van Praag, Catherine Mumenthaler, Claudine Ott, Stefan A. Kolb, Gundula Hebisch, Rudolf Steiner

Instructions for Authors

Instructions for authors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine